18F-fluoride PET in osteoporosis

PET Clinics

Volumn 5, Issue 3, 2010, Pages 259-274

  Frost, Michelle L ^a   Blake, Glen M ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bone perfusion; Bone turnover; Osteoporosis

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18;

ARTICLE; BONE METABOLISM; BONE TURNOVER; FRACTURE HEALING; HUMAN; ISOTOPE TRACING; METABOLIC BONE DISEASE; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 79954610518     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2010.02.007     Document Type: Article

References (97)

1. Consensus development conference: diagnosis prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-50.
2. Boonen S, Singer AJ. Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin 2008;24(6):1781-8.
3. Department of Health. Advisory Group on Osteoporosis. London: Department of Health; 1994.
4. Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep 2008; 10(2):92-6.
5. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005;20(7):1185-94. (Pubitemid 40863806)
6. World Health Organization (WHO). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129, World Health Organization, Geneva, Switzerland.
7. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007;177(6):575-80. (Pubitemid 47437054)
8. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007;18(8): 1033-46. (Pubitemid 47020000)
9. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19(4):385-97.
10. Kanis JA, McCloskey EV, Johansson H, et al. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008;19(10): 1395-408.
11. Heaney RP. Is the paradigm shifting? Bone 2003;33: 457-65. (Pubitemid 37222371)
12. Kleerekoper M. Overview of osteoporosis treatment. In: Rosen CJ, Compston JE, Lian JB, editors. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th edition. Washington, DC: American Society of Bone and Mineral Research; 2008. p. 220-1.
13. Garnero P, Sornay-Rendu E, Duboef F, et al. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 1999;11(Suppl 6):55-65.
14. Johnell O, Oden A, De Laet C, et al. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 2002;13:523-6. (Pubitemid 34790623)
15. Eastell R, Barton I, Hannon RA. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003;18: 1051-6. (Pubitemid 37294942)
16. Hochberg MC, Greenspan S, Wasnich RD, et al. Changes in bone density and turnover explain the reduction in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 2002;87:1586-92. (Pubitemid 34615244)
17. Compston JE, Croucher PI. Histomorphometric assessment of trabecular bone remodelling in osteoporosis. Bone Miner 1991;14:91-102.
18. Martin KJ, Olgaard K, on behalf of the Bone Turnover Work Group. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004;43:558-65. (Pubitemid 38298216)
19. Delmas PD, Eastell R, Garnero P, et al. for the Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000;11(Suppl 6):2-17.
20. Seibel MJ. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 2000;11(Suppl 6):18-29.
21. 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res 2000;15:763-9. (Pubitemid 30174030)
22. 18F-fluoride positron emission tomography. J Bone Miner Res 2002;17:854-9. (Pubitemid 34441902)
23. 18F-fluoride positron emission tomography. J Bone Miner Res 2003;18:2215-22. (Pubitemid 37463315)
24. Frost ML, Cook GJR, Blake GM, et al. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. J Bone Miner Res 2004; 19:1797-804. (Pubitemid 41103430)
25. 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. J Clin Densitom 2006;10:46-54. (Pubitemid 46199275)
26. 18F-fluoride PET study of treatment-naïve and treated postmenopausal women. Bone 2009;45(5):942-8.
27. 18F-fluoride PET scans. J Nucl Med 2004;45:1493-500. (Pubitemid 47618503)
28. Hawkins RA, Choi Y, Huang S-C, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 1992;33:633-42.
29. 18F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med 2005;46:1650-8. (Pubitemid 46211589)
30. Moore AE, Blake GM, Taylor KA, et al. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment. J Bone Miner Res 2009. [Epub ahead of print].
31. 18F-fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab 1993;77:949-55. (Pubitemid 23301469)
32. 18F-fluoride PET: correlation with bone histomorphometry. J Nucl Med 2001;42:1091-100. (Pubitemid 32595310)
33. 18F-fluoride ion PET and quantitative CT. J Nucl Med 2003;44: 117-24. (Pubitemid 36077722)
34. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med 1997; 38:1970-6. (Pubitemid 28030932)
35. 18F-fluoride ion PET in porcine vertebrae. J Bone Miner Res 1998; 13(8):1328-36. (Pubitemid 28373335)
36. 18F-fluoride ion positron emission tomography. Eur J Nucl Med 2002;29:907-14. (Pubitemid 34671296)
37. 18F-fluoride PET: a prospective study. J Nucl Med 2009;50(11): 1808-14.
38. 18F-fluoride PET indicates reduced bone formation in severe glucocorticoid-induced osteoporosis. Nuklearmedizin 1998;37(2):76-9. (Pubitemid 28158837)
39. Blau M, Nagler W, Bender MA. Fluorine-18: a new isotope for bone scanning. J Nucl Med 1962;3: 332-4.
40. Ishiguro K, Nakagaki H, Tsuboi S, et al. Distribution of fluoride in cortical bone of human rib. Calcif Tissue Int 1993;52:278-82. (Pubitemid 23097159)
41. Narita N, Kato K, Nakagaki H, et al. Distribution of fluoride concentration in the rat's bone. Calcif Tissue Int 1990;46:200-4. (Pubitemid 20084077)
42. 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008;49(1):68-78.
43. 99mTc-methylene diphosphonate. Semin Nucl Med 2001;31(1):28-49. (Pubitemid 32060651)
44. Hosking DJ, Chamberlain MJ. Studies in man with 18F. Clin Sci 1972;42(2):153-61.
45. 18F in rabbit bone. Clin Phys Physiol Meas 1986; 7(4):333-43. (Pubitemid 17218957)
46. 18F PET. J Nucl Med 1999;40(10):1623-9. (Pubitemid 29471151)
47. Schirrmeister H, Glatting G, Hetzel J, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001;42(12): 1800-4. (Pubitemid 34016348)
48. Hetzel M, Arslandemir C, König HH, et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003; 18(12):2206-14. (Pubitemid 37463314)
49. 18F-fluoride PET/CT. J Nucl Med 2004;45(2):272-8. (Pubitemid 47618648)
50. 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J Nucl Med 2008;49:700-7. (Pubitemid 351717533)
51. Arlot ME, Delmas PD, Chappard D, et al. Trabecular and endocortical bone remodelling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporos Int 1990;1:41-9.
52. Eriksen EF, Hodgson SF, Eastell R, et al. Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990;5:311-9. (Pubitemid 20276829)
53. Garcia-Carasco M, de Vernejoul MC, Sterkers Y, et al. Decreased bone formation in osteoporotic patients compared with age-matched controls. Calcif Tissue Int 1989;44:173-5. (Pubitemid 19076624)
54. Kimmel DB, Recker RR, Gallagher JC, et al. A comparison of iliac bone histomorphometric data in postmenopausal osteoporotic and normal subjects. Bone Miner 1990;11:217-35. (Pubitemid 20375787)
55. Parfitt AM, Villanueva AR, Foldes J, et al. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 1995;10:466-73.
56. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 2002;966: 73-81. (Pubitemid 34729163)
57. Prisby RD, Ramsey MW, Behnke BJ, et al. Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats. J Bone Miner Res 2007;22:1280-8. (Pubitemid 351339710)
58. McCarthy I. The physiology of bone blood flow: a review. J Bone Joint Surg Am 2006;88(Suppl 3): 4-9. (Pubitemid 44706476)
59. Bloomfield SA, Hogan HA, Delp MD. Decreases in bone blood flow and bone material properties in aging Fischer-344 rats. Clin Orthop Relat Res 2002;396:248-57. (Pubitemid 34207978)
60. Griffith JF, Yeung DK, Tsang PH, et al. Compromised bone marrow perfusion in osteoporosis. J Bone Miner Res 2008;23:1068-75. (Pubitemid 351915729)
61. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S. Remodeling and vascular spaces in bone. J Bone Miner Res 2007;22:1-6. (Pubitemid 46032591)
62. Vogt MT, Cauley JA, Kuller LH, et al. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res 1997;12:283-9. (Pubitemid 27086311)
63. Alagiakrishnan K, Juby A, Hanley D, et al. Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci 2003;58:362-6. (Pubitemid 36397053)
64. Sanada M, Taguchi A, Higashi Y, et al. Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis 2004;176: 387-92. (Pubitemid 39369530)
65. Laroche M, Ludot I, Thiechart M, et al. Study of the intraosseous vessels of the femoral head in patients with fractures of the femoral neck or osteoarthritis of the hip. Osteoporos Int 1995;5:213-7.
66. Reeve J, Arlot M, Wootton R, et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. J Clin Endocrinol Metab 1988;66:1124-31.
67. Van Dyke D, Anger HO, Yano Y, et al. Bone blood flow shown with F18 and the positron camera. Am J Physiol 1965;209:65-70.
68. Shih TT, Liu HC, Chang CJ, et al. Correlation of MR lumbar spine bone marrow perfusion with bone mineral density in female subjects. Radiology 2004;233(1):121-8. (Pubitemid 39280966)
69. Griffith JF, Yeung DK, Antonio GE, et al. Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 2006;241:831-8. (Pubitemid 46190550)
70. Schiepers C, Broos P, Miserez M, et al. Measurement of skeletal flow with positron emission tomography and 18F-fluoride in femoral head osteonecrosis. Arch Orthop Trauma Surg 1998;118(3):131-5. (Pubitemid 29027681)
71. Ullmark G, Sörensen J, Långström B, et al. Bone regeneration 6 years after impaction bone grafting: a PET analysis. Acta Orthop 2007;78(2):201-5. (Pubitemid 46676660)
72. 18F]-positron emission tomography. Int J Oral Maxillofac Surg 1999;28(5):349-55.
73. 18F]fluoride ion positron emission tomography. Eur J Nucl Med 1999;26(6):615-24. (Pubitemid 29263632)
74. 18F]fluoride PET; a pilot study. Mol Imaging Biol 2008;10(5):288-93.
75. Andresen R, Werner HJ, Schober HC. Contribution of the cortical shell of vertebrae to mechanical behaviour of the lumbar vertebrae with implications for predicting fracture risk. Br J Radiol 1998;71: 759-65. (Pubitemid 28342462)
76. Rico H. The therapy of osteoporosis and the importance of cortical bone. Calcif Tissue Int 1997;61: 431-2.
77. Cheong JM, Gunaratna NS, McCabe GP, et al. Bone seeking labels as markers for bone turnover: effect of dosing schedule on labeling various bone sites in rats. Calcif Tissue Int 2009;85:440-50.
78. Riggs BL, Melton LJ, Robb RA, et al. A populationbased assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008;23:205-14. (Pubitemid 351160034)
79. Tsurusaki K, Ito M, Hayashi K. Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT). Br J Radiol 2000;73:14-22. (Pubitemid 30105402)
80. Meier DE, Orwoll ES, Jones JM. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med 1984;101:605-12. (Pubitemid 15223296)
81. Rüegsegger P, Durand EP, Dambacher MA. Differential effects of aging and disease on trabecular and compact bone density of the radius. Bone 1991;12:99-105.
82. Vico L, Collet P, Guignandon A, et al. Effects of longterm microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000;355:1607-11. (Pubitemid 30240506)
83. Turner CH. Site-specific skeletal effects of exercise: importance of interstitial fluid pressure. Bone 1999; 24:161-2. (Pubitemid 29094556)
84. Byers RJ, Denton J, Hoyland JA, et al. Differential patterns of altered bone formation in different bone compartments in established osteoporosis. J Clin Pathol 1999;52:23-8. (Pubitemid 29023503)
85. Eventov I, Frisch B, Cohen Z, et al. Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: a prospective study of 102 cases of femoral neck fractures. Bone 1991;12:1-6.
86. Pødenphant J, Engel U. Regional variations in histomorphometric bone dynamics from the skeleton of an osteoporotic woman. Calcif Tissue Int 1987;40:184-8.
87. Ninomiya JT, Tracy RP, Calore JD, et al. Heterogeneity of human bone. J Bone Miner Res 1990;5:933-8. (Pubitemid 20307110)
88. Carnevale V, Dicembrino F, Frusciante V, et al. Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss. J Nucl Med 2000;41:1478-83.
89. Israel O, Lubushitzky R, Frenkel A, et al. Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis. J Nucl Med 1994;35:1155-8.
90. Frost ML, Cook GJR, Blake GM, et al. A comparison of regional bone turnover at the spine and hip in postmenopausal women with osteoporosis. Osteoporos Int 2004;15(Suppl 2):40-1.
91. Giannoudis P, Tzioupis C, Almalki T, et al. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 2007;38(Suppl 1):S90-9. (Pubitemid 46440934)
92. Barnes GL, Kakar S, Vora S, et al. Stimulation of fracture- healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 2008; 90(Suppl 1):120-7. (Pubitemid 351329130)
93. 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging 2007;34(8):1291-301. (Pubitemid 47290654)
94. Silva MJ, Uthgenannt BA, Rutlin JR, et al. In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna. Bone 2006;39(2):229-36. (Pubitemid 44183796)
95. Blake GM, Frost ML, Fogelman I. Quantitative radionuclide studies of bone. J Nucl Med 2009;50(11): 1747-50.
96. Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 2002;17:2094-105. (Pubitemid 35416745)
97. Goodman WG, Coburn JW, Slatopolsky E, et al. Renal osteodystrophy in adults and children. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 347-63.